News & Updates
Filter by Specialty:
VT ablation reduces ICD therapy, hospitalization for arrhythmia
Ablation of ventricular tachycardia (VT) before placement of an implantable cardioverter-defibrillator (ICD) is associated with a reduced risk of appropriate ICD therapy or ventricular arrhythmia (VA)-related hospitalization in patients with ischaemic cardiomyopathy (ICM) and chronic total occlusion of an infarct-related artery (IRA-CTO), findings from the PREVENTIVE VT trial have shown.
VT ablation reduces ICD therapy, hospitalization for arrhythmia
23 Apr 2024Supplementation with essential amino acid improves liver health in teen girls with PCOS
Short-term supplementation with a selective essential amino acid (EAA)-containing product significantly improved liver-related outcomes among adolescent girls with polycystic ovarian syndrome (PCOS) in a recent study.
Supplementation with essential amino acid improves liver health in teen girls with PCOS
23 Apr 2024Rapid response with a CDK4/6 inhibitor in an elderly patient with HR-positive, HER2-negative advanced breast cancer and comorbidities
Department of Clinical Oncology
School of Clinical Medicine
University of Hong Kong
The patient was a 70-year-old female who presented with a large, fungating left breast mass in September 2022. Although first symptoms were noticed approximately a year earlier, the patient did not seek consultation sooner for fear of cancer diagnosis. Upon examination, the mass occupied the entire left breast. The patient also suffered from shortness of breath and left breast pain. These symptoms worsened, resulting in hospitalization.
Rapid response with a CDK4/6 inhibitor in an elderly patient with HR-positive, HER2-negative advanced breast cancer and comorbidities
23 Apr 2024Switching from cetuximab to bevacizumab associated with acceptable survival, reduced derm toxicity in mCRC
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab leads to acceptable survival outcomes and a reduction in severe dermatological toxicities in patients with RAS wild-type (RASwt) metastatic colorectal cancer (mCRC), according to the results of a single-arm phase II HYBRID trial.
Switching from cetuximab to bevacizumab associated with acceptable survival, reduced derm toxicity in mCRC
23 Apr 2024A sock to detect diabetic, CV complications?
A study presented at EHRA 2024 demonstrated the potential of a sock fitted with a ballistocardiogram (BCG) sensor to predict diabetic complications by identifying foot pressure distribution patterns, as well as to detect cardiovascular issues.
A sock to detect diabetic, CV complications?
22 Apr 2024People with depression gain most CV benefits from physical activity
Individuals who engage in physical activities (PA) enjoy a reduced risk of cardiovascular disease (CVD), especially those suffering from depression, with a recent study showing that PA acts through the brain’s stress-related activity.
People with depression gain most CV benefits from physical activity
22 Apr 2024Lower VTE risk seen in atopic dermatitis vs other inflammatory diseases
Atopic dermatitis (AD) does not seem to induce an increase in the risk of venous thromboembolism (VTE) when considering underlying risk factors, suggests a study. Moreover, patients with AD show a lower VTE risk than those with rheumatoid arthritis (RA), Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA), or ankylosing spondylitis (AS).